86 related articles for article (PubMed ID: 20021972)
1. [Uterine papillary serous carcinoma: report of a case].
Dai L; Song QJ
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):557-8. PubMed ID: 20021972
[No Abstract] [Full Text] [Related]
2. [Proliferating serous papillary cystadenoma of the borderline type in myometrium of the fundus uteri].
Grouls V
Geburtshilfe Frauenheilkd; 1996 Oct; 56(10):559-62. PubMed ID: 9036071
[TBL] [Abstract][Full Text] [Related]
3. Re: Uterine papillary serous carcinoma: patterns of metastatic spread.
Thomas GM
Gynecol Oncol; 1995 Jun; 57(3):437-8. PubMed ID: 7774855
[No Abstract] [Full Text] [Related]
4. Papillary serous carcinoma of the uterus arising in an adenomyoma.
Griffin M; Parai S; Ghatage P; Dimakulangan A
Acta Cytol; 1996; 40(4):849-50. PubMed ID: 8693916
[No Abstract] [Full Text] [Related]
5. HER2/neu overexpression: has the Achilles' heel of uterine serous papillary carcinoma been exposed?
Santin AD
Gynecol Oncol; 2003 Mar; 88(3):263-5. PubMed ID: 12648572
[No Abstract] [Full Text] [Related]
6. Papillary serous carcinoma of ovarian type of the testis with borderline differentiation.
Guarch R; Rivas A; Puras A; Pesce C
Histopathology; 2005 May; 46(5):588-90. PubMed ID: 15842644
[No Abstract] [Full Text] [Related]
7. GLUT1 and p63 expression in endometrial intraepithelial and uterine serous papillary carcinoma.
Idrees MT; Schlosshauer P; Li G; Burstein DE
Histopathology; 2006 Jul; 49(1):75-81. PubMed ID: 16842248
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of Her-2/neu status in patients with uterine papillary serous carcinoma].
Ren YL; Wang HY; Zhou XY; Shan BE; Yang WT; Shen L; Shi DR
Zhonghua Fu Chan Ke Za Zhi; 2010 May; 45(5):367-71. PubMed ID: 20646447
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic oophorectomy: a morphologic and immunohistochemical study.
Schlosshauer PW; Cohen CJ; Penault-Llorca F; Miranda CR; Bignon YJ; Dauplat J; Deligdisch L
Cancer; 2003 Dec; 98(12):2599-606. PubMed ID: 14669279
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal CA125 detection of sporadic papillary serous carcinoma of the peritoneum.
Skates S; Troiano R; Knapp RC
Int J Gynecol Cancer; 2003; 13(5):693-6. PubMed ID: 14675358
[TBL] [Abstract][Full Text] [Related]
11. Uterine papillary serous carcinoma (UPSC): a clinicopathologic study of 30 cases.
Kato DT; Ferry JA; Goodman A; Sullinger J; Scully RE; Goff BA; Fuller AF; Rice LW
Gynecol Oncol; 1995 Dec; 59(3):384-9. PubMed ID: 8522260
[TBL] [Abstract][Full Text] [Related]
12. [Villoglandular adenocarcinoma of cervix:a clinicopathological study].
Liu ZC; Zheng L; Huo YL; Yang XH; Gao AF; Cui XJ
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):338-9. PubMed ID: 20654158
[No Abstract] [Full Text] [Related]
13. Metastatic uterine papillary serous carcinoma to the pericardium.
Ramirez PT; Ramondetta LM; Burke TW; Gershenson DM; Brewer MA
Gynecol Oncol; 2001 Oct; 83(1):135-7. PubMed ID: 11585425
[TBL] [Abstract][Full Text] [Related]
14. Uterine papillary serous carcinoma: what have we learned over the past quarter century?
Goff BA
Gynecol Oncol; 2005 Sep; 98(3):341-3. PubMed ID: 16111527
[No Abstract] [Full Text] [Related]
15. [Uterine papillary serous carcinoma].
Kedzia H; Spaczyński M
Ginekol Pol; 1994 Oct; 65(10):587-92. PubMed ID: 7729721
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.
Santin AD; Diamandis EP; Bellone S; Marizzoni M; Bandiera E; Palmieri M; Papasakelariou C; Katsaros D; Burnett A; Pecorelli S
Am J Obstet Gynecol; 2006 May; 194(5):1296-302. PubMed ID: 16647913
[TBL] [Abstract][Full Text] [Related]
17. Uterine papillary serous carcinoma presenting as distant lymph node metastasis.
Ng JS; Han AC; Edelson MI; Rosenblum NG
Gynecol Oncol; 2001 Mar; 80(3):417-20. PubMed ID: 11263944
[TBL] [Abstract][Full Text] [Related]
18. p53 protein overexpression: a strong prognostic factor in uterine papillary serous carcinoma.
Bancher-Todesca D; Gitsch G; Williams KE; Kohlberger P; Neunteufel W; Obermair A; Heinze G; Breitenecker G; Hacker NF
Gynecol Oncol; 1998 Oct; 71(1):59-63. PubMed ID: 9784320
[TBL] [Abstract][Full Text] [Related]
19. Role of cytoreduction in stage III and IV uterine papillary serous carcinoma.
Thomas MB; Mariani A; Cliby WA; Keeney GL; Podratz KC; Dowdy SC
Gynecol Oncol; 2007 Nov; 107(2):190-3. PubMed ID: 17825394
[TBL] [Abstract][Full Text] [Related]
20. [Uterine papillary serous carcinoma--a different kind of tumor].
Steinman N; Avni A
Harefuah; 1999 May; 136(10):810-2. PubMed ID: 10955120
[No Abstract] [Full Text] [Related]
[Next] [New Search]
